1.Virus Isolation from the First Patient with SARS-CoV-2 in Korea
Wan Beom PARK ; Nak Jung KWON ; Su Jin CHOI ; Chang Kyung KANG ; Pyoeng Gyun CHOE ; Jin Yong KIM ; Jiyoung YUN ; Gir Won LEE ; Moon Woo SEONG ; Nam Joong KIM ; Jeong Sun SEO ; Myoung don OH
Journal of Korean Medical Science 2020;35(7):84-
Novel coronavirus (SARS-CoV-2) is found to cause a large outbreak started from Wuhan since December 2019 in China and SARS-CoV-2 infections have been reported with epidemiological linkage to China in 25 countries until now. We isolated SARS-CoV-2 from the oropharyngeal sample obtained from the patient with the first laboratory-confirmed SARS-CoV-2 infection in Korea. Cytopathic effects of SARS-CoV-2 in the Vero cell cultures were confluent 3 days after the first blind passage of the sample. Coronavirus was confirmed with spherical particle having a fringe reminiscent of crown on transmission electron microscopy. Phylogenetic analyses of whole genome sequences showed that it clustered with other SARS-CoV-2 reported from Wuhan.
China
;
Coronavirus
;
Crowns
;
Genome
;
Humans
;
Korea
;
Microscopy, Electron
;
Microscopy, Electron, Transmission
;
Phylogeny
;
Vero Cells
2.Virus Isolation from the First Patient with SARS-CoV-2 in Korea
Wan Beom PARK ; Nak Jung KWON ; Su Jin CHOI ; Chang Kyung KANG ; Pyoeng Gyun CHOE ; Jin Yong KIM ; Jiyoung YUN ; Gir Won LEE ; Moon Woo SEONG ; Nam Joong KIM ; Jeong Sun SEO ; Myoung don OH
Journal of Korean Medical Science 2020;35(7):e84-
Novel coronavirus (SARS-CoV-2) is found to cause a large outbreak started from Wuhan since December 2019 in China and SARS-CoV-2 infections have been reported with epidemiological linkage to China in 25 countries until now. We isolated SARS-CoV-2 from the oropharyngeal sample obtained from the patient with the first laboratory-confirmed SARS-CoV-2 infection in Korea. Cytopathic effects of SARS-CoV-2 in the Vero cell cultures were confluent 3 days after the first blind passage of the sample. Coronavirus was confirmed with spherical particle having a fringe reminiscent of crown on transmission electron microscopy. Phylogenetic analyses of whole genome sequences showed that it clustered with other SARS-CoV-2 reported from Wuhan.
3.Calcified Macroplastique Substance: A Rare Cause of Recurrent Gross Hematuria after Endoscopic Injection
Min Hae SEO ; Ji Yeon SONG ; Jae Min CHUNG ; Sang Don LEE ; Su Young KIM ; Seong Heon KIM
Childhood Kidney Diseases 2018;22(2):71-74
Endoscopic subureteral injection for treatment of vesicoureteral reflux (VUR) is known to be safe and efficient due to its minimal invasive nature. Being non-migratory, non-antigenic, and biocompatible, Macroplastique (Polydimethylsiloxane) is likely to be stable over time. A 5-year-old boy with a past history of subureteral administration of Macroplastique for unilateral Grade V VUR 4 years ago presented with recurrent gross and microscopic hematuria, along with suprapubic pain. On computed tomography (CT) abdomen, calcified material, suspected to be a stone, was visualized in the bladder. On diagnostic cystoscopy, calcification was seen around the orifice site where Macroplastique injection had been performed. We removed the calcific material by Holmium laser. Endoscopic subureteric implantation has several advantages, but nevertheless, vigilance is needed to detect long-term complications, especially in patients with gross or microscopic hematuria.
Abdomen
;
Child, Preschool
;
Cystoscopy
;
Hematuria
;
Humans
;
Lasers, Solid-State
;
Male
;
Urinary Bladder
;
Vesico-Ureteral Reflux
4.Clinical Practice Guideline for Stroke Rehabilitation in Korea 2016.
Deog Young KIM ; Yun Hee KIM ; Jongmin LEE ; Won Hyuk CHANG ; Min Wook KIM ; Sung Bom PYUN ; Woo Kyoung YOO ; Suk Hoon OHN ; Ki Deok PARK ; Byung Mo OH ; Seong Hoon LIM ; Kang Jae JUNG ; Byung Ju RYU ; Sun IM ; Sung Ju JEE ; Han Gil SEO ; Ueon Woo RAH ; Joo Hyun PARK ; Min Kyun SOHN ; Min Ho CHUN ; Hee Suk SHIN ; Seong Jae LEE ; Yang Soo LEE ; Si Woon PARK ; Yoon Ghil PARK ; Nam Jong PAIK ; Sam Gyu LEE ; Ju Kang LEE ; Seong Eun KOH ; Don Kyu KIM ; Geun Young PARK ; Yong Il SHIN ; Myoung Hwan KO ; Yong Wook KIM ; Seung Don YOO ; Eun Joo KIM ; Min Kyun OH ; Jae Hyeok CHANG ; Se Hee JUNG ; Tae Woo KIM ; Won Seok KIM ; Dae Hyun KIM ; Tai Hwan PARK ; Kwan Sung LEE ; Byong Yong HWANG ; Young Jin SONG
Brain & Neurorehabilitation 2017;10(Suppl 1):e11-
“Clinical Practice Guideline for Stroke Rehabilitation in Korea 2016” is the 3rd edition of clinical practice guideline (CPG) for stroke rehabilitation in Korea, which updates the 2nd edition published in 2014. Forty-two specialists in stroke rehabilitation from 21 universities and 4 rehabilitation hospitals and 4 consultants participated in this update. The purpose of this CPG is to provide optimum practical guidelines for stroke rehabilitation teams to make a decision when they manage stroke patients and ultimately, to help stroke patients obtain maximal functional recovery and return to the society. The recent two CPGs from Canada (2015) and USA (2016) and articles that were published following the 2nd edition were used to develop this 3rd edition of CPG for stroke rehabilitation in Korea. The chosen articles' level of evidence and grade of recommendation were decided by the criteria of Scotland (2010) and the formal consensus was derived by the nominal group technique. The levels of evidence range from 1++ to 4 and the grades of recommendation range from A to D. Good Practice Point was recommended as best practice based on the clinical experience of the guideline developmental group. The draft of the developed CPG was reviewed by the experts group in the public hearings and then revised. “Clinical Practice Guideline for Stroke Rehabilitation in Korea 2016” consists of ‘Chapter 1; Introduction of Stroke Rehabilitation’, ‘Chapter 2; Rehabilitation for Stroke Syndrome, ‘Chapter 3; Rehabilitation for Returning to the Society’, and ‘Chapter 4; Advanced Technique for Stroke Rehabilitation’. “Clinical Practice Guideline for Stroke Rehabilitation in Korea 2016” will provide direction and standardization for acute, subacute and chronic stroke rehabilitation in Korea.
Canada
;
Consensus
;
Consultants
;
Humans
;
Korea*
;
Practice Guidelines as Topic
;
Rehabilitation*
;
Scotland
;
Specialization
;
Stroke*
5.Is Endoscopic Resection for Type 1 Gastric Neuroendocrine Tumors Essential for Treatment?: Multicenter, Retrospective Long-term Follow-up Results.
Han Sol LEE ; Seong Woo JEON ; Gwang Ha KIM ; Jin Il KIM ; Il Kwun CHUNG ; Sam Ryong JEE ; Heung Up KIM ; Geom Seog SEO ; Gwang Ho BAIK ; Kee Don CHOI ; Jeong Seop MOON
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2016;16(1):13-18
BACKGROUND/AIMS: Treatment of gastric neuroendocrine tumors is determined by type and size of the lesion. This study aimed to compare the long-term efficacy of observation and endoscopic resection for type 1 gastric neuroendocrine tumors without metastasis. MATERIALS AND METHODS: Among the 223 cases of gastric neuroendocrine tumors diagnosed between January 1996 and December 2011, 104 cases were type 1 gastric neuroendocrine tumors. Sixty-seven patients were treated endoscopically and 27 patients were observed without treatment. Endoscopic mucosal resection, endoscopic submucosal dissection, and polypectomy were the methods used for endoscopic treatment. Therapeutic efficacy and rates of complication and recurrence were evaluated retrospectively. RESULTS: In the endoscopic resection group, complete resection was observed in 53 patients (79.1%), and recurrence was observed in 14 patients (20.9%). On analysis of the observation group, no change was observed in 19 patients (70.4%), and tumor progression was observed in 8 patients (29.6%). Median follow-up duration was 49 months (31~210 months). No mortality was reported in either group during follow-up. CONCLUSIONS: Observation of type 1 gastric neuroendocrine tumors without metastasis yields results similar to those produced by endoscopic resection. Observation alone may be a safe treatment.
Endoscopy
;
Follow-Up Studies*
;
Humans
;
Mortality
;
Neoplasm Metastasis
;
Neuroendocrine Tumors*
;
Recurrence
;
Retrospective Studies*
;
Stomach
6.Predictive factors of prolonged warm ischemic time (> or =30 minutes) during partial nephrectomy under pneumoperitoneum.
Kwang Jin KO ; Don Kyoung CHOI ; Seung Jea SHIN ; Hyun Soo RYOO ; Tae Sun KIM ; Wan SONG ; Hwang Gyun JEON ; Byong Chang JEONG ; Seong Il SEO
Korean Journal of Urology 2015;56(11):742-748
PURPOSE: Current clinical data support a safe warm ischemia time (WIT) limit of 30 minutes during laparoscopic partial nephrectomy (LPN) or robot-assisted partial nephrectomy (RPN). We evaluated independent factors predicting prolonged WIT (more than 30 minutes) after LPN or RPN. MATERIALS AND METHODS: A retrospective data review was performed for 317 consecutive patients who underwent LPN or RPN performed by the same surgeon from October 2007 to May 2013. Patients were divided into two groups: group A was defined as prolonged WIT (> or =30 minutes) and group B as short WIT (<30 minutes). We compared clinical factors between the two groups to evaluate predictors of prolonged WIT. RESULTS: Among 317 consecutive patients, 80 were in the prolonged WIT group. Baseline characteristics were not significantly different between the groups. In the univariable analysis, PADUA (preoperative aspects and dimensions used for an anatomical) score (p=0.001), approach method (transperitoneal or retroperitoneal approach; p<0.001), and surgeon experience (p<0.001) were significantly associated with prolonged WIT. In the multivariable analysis, PADUA score (p=0.032), tumor size (> or =25 mm; odds ratio, 2.98; 95% confidence interval, 1.48-5.96; p=0.002), and surgeon experience (p<0.001) were independent predictors of prolonged WIT. CONCLUSIONS: Surgeon experience, tumor size, and PADUA score predicted prolonged WIT after RPN or LPN. Among these factors, increasing surgical experience with LPN or RPN is the most important factor for preventing prolonged WIT.
Adult
;
Aged
;
Carcinoma, Renal Cell/pathology/*surgery
;
Clinical Competence
;
Female
;
Humans
;
Intraoperative Period
;
Kidney Neoplasms/pathology/*surgery
;
Laparoscopy/methods
;
Male
;
Middle Aged
;
Nephrectomy/*methods
;
Pneumoperitoneum, Artificial/*methods
;
Retrospective Studies
;
Risk Factors
;
Robotic Surgical Procedures/methods
;
Warm Ischemia/*methods
7.Surgical treatment for prostate cancer.
Don Kyoung CHOI ; Seong Il SEO
Journal of the Korean Medical Association 2015;58(1):15-20
With the recent increase in the elderly population, and the Westernization of the diet and increased consumption of meat products, a significant rise in the incidence of prostate cancer has been noted in the Republic of Korea. In cases with localized prostate cancer and sufficiently long life expectancy, the standard treatment is surgical resection of the prostate. Such surgical treatment is so far the only modality demonstrated through randomized prospective studies to be beneficial in terms of disease-specific survival; this procedure involves not only surgical removal of the prostate but also pelvic lymphadenectomy for accurate staging and neurovascular bundle preservation to aid in postoperative functional recovery. Prostatectomy can be carried out either with an open technique, laparoscopically, or under robot assistance. Reviews of the literature and meta-analyses have shown that laparoscopic and robot-assisted procedures offer significant reductions in blood loss and transfusion rates and advantages in terms of recovery from postoperative complications such as incontinence and impotence over open prostatectomy. However, no long-term oncologic outcomes are available for laparoscopic or robot-assisted procedures, and the long-term prevalence of incontinence and impotence for these two methods doesnot differ significantly from those for open prostatectomy, despite the laparoscopic and robot-assisted procedures being far more costly. Therefore, surgical treatment of prostate cancer should be carefully decided on following ample deliberation of various factors including the stage, age, comorbidities, and economic status of the patient and provision of sufficient information to the patient.
Aged
;
Comorbidity
;
Diet
;
Erectile Dysfunction
;
Humans
;
Incidence
;
Life Expectancy
;
Lymph Node Excision
;
Male
;
Meat Products
;
Postoperative Complications
;
Prevalence
;
Prostate
;
Prostatectomy
;
Prostatic Neoplasms*
;
Republic of Korea
;
Urologic Surgical Procedures
8.Factors Associated with Ischemic Stroke on Therapeutic Anticoagulation in Patients with Nonvalvular Atrial Fibrillation.
Young Dae KIM ; Kyung Yul LEE ; Hyo Suk NAM ; Sang Won HAN ; Jong Yun LEE ; Han Jin CHO ; Gyu Sik KIM ; Seo Hyun KIM ; Myoung Jin CHA ; Seong Hwan AHN ; Seung Hun OH ; Kee Ook LEE ; Yo Han JUNG ; Hye Yeon CHOI ; Sang Don HAN ; Hye Sun LEE ; Chung Mo NAM ; Eun Hye KIM ; Ki Jeong LEE ; Dongbeom SONG ; Hui Nam PARK ; Ji Hoe HEO
Yonsei Medical Journal 2015;56(2):410-417
PURPOSE: In this study, we investigated the stroke mechanism and the factors associated with ischemic stroke in patients with nonvalvular atrial fibrillation (NVAF) who were on optimal oral anticoagulation with warfarin. MATERIALS AND METHODS: This was a multicenter case-control study. The cases were consecutive patients with NVAF who developed cerebral infarction or transient ischemic attack (TIA) while on warfarin therapy with an international normalized ratio (INR) > or =2 between January 2007 and December 2011. The controls were patients with NVAF without ischemic stroke who were on warfarin therapy for more than 1 year with a mean INR > or =2 during the same time period. We also determined etiologic mechanisms of stroke in cases. RESULTS: Among 3569 consecutive patients with cerebral infarction or TIA who had NVAF, 55 (1.5%) patients had INR > or =2 at admission. The most common stroke mechanism was cardioembolism (76.0%). Multivariate analysis demonstrated that smoking and history of previous ischemic stroke were independently associated with cases. High CHADS2 score (> or =3) or CHA2DS2-VASc score (> or =5), in particular, with previous ischemic stroke along with > or =1 point of other components of CHADS2 score or > or =3 points of other components of CHA2DS2-VASc score was a significant predictor for development of ischemic stroke. CONCLUSION: NVAF patients with high CHADS2/CHA2DS2-VASc scores and a previous ischemic stroke or smoking history are at high risk of stroke despite optimal warfarin treatment. Some other measures to reduce the risk of stroke would be necessary in those specific groups of patients.
Aged
;
Aged, 80 and over
;
Anticoagulants/adverse effects/*therapeutic use
;
Atrial Fibrillation/*complications
;
Cardiovascular Diseases
;
Case-Control Studies
;
Cerebral Infarction/complications
;
Female
;
Humans
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Risk Factors
;
Stroke/etiology/*prevention & control
;
Warfarin/adverse effects/*therapeutic use
9.Factors Associated with Ischemic Stroke on Therapeutic Anticoagulation in Patients with Nonvalvular Atrial Fibrillation.
Young Dae KIM ; Kyung Yul LEE ; Hyo Suk NAM ; Sang Won HAN ; Jong Yun LEE ; Han Jin CHO ; Gyu Sik KIM ; Seo Hyun KIM ; Myoung Jin CHA ; Seong Hwan AHN ; Seung Hun OH ; Kee Ook LEE ; Yo Han JUNG ; Hye Yeon CHOI ; Sang Don HAN ; Hye Sun LEE ; Chung Mo NAM ; Eun Hye KIM ; Ki Jeong LEE ; Dongbeom SONG ; Hui Nam PARK ; Ji Hoe HEO
Yonsei Medical Journal 2015;56(2):410-417
PURPOSE: In this study, we investigated the stroke mechanism and the factors associated with ischemic stroke in patients with nonvalvular atrial fibrillation (NVAF) who were on optimal oral anticoagulation with warfarin. MATERIALS AND METHODS: This was a multicenter case-control study. The cases were consecutive patients with NVAF who developed cerebral infarction or transient ischemic attack (TIA) while on warfarin therapy with an international normalized ratio (INR) > or =2 between January 2007 and December 2011. The controls were patients with NVAF without ischemic stroke who were on warfarin therapy for more than 1 year with a mean INR > or =2 during the same time period. We also determined etiologic mechanisms of stroke in cases. RESULTS: Among 3569 consecutive patients with cerebral infarction or TIA who had NVAF, 55 (1.5%) patients had INR > or =2 at admission. The most common stroke mechanism was cardioembolism (76.0%). Multivariate analysis demonstrated that smoking and history of previous ischemic stroke were independently associated with cases. High CHADS2 score (> or =3) or CHA2DS2-VASc score (> or =5), in particular, with previous ischemic stroke along with > or =1 point of other components of CHADS2 score or > or =3 points of other components of CHA2DS2-VASc score was a significant predictor for development of ischemic stroke. CONCLUSION: NVAF patients with high CHADS2/CHA2DS2-VASc scores and a previous ischemic stroke or smoking history are at high risk of stroke despite optimal warfarin treatment. Some other measures to reduce the risk of stroke would be necessary in those specific groups of patients.
Aged
;
Aged, 80 and over
;
Anticoagulants/adverse effects/*therapeutic use
;
Atrial Fibrillation/*complications
;
Cardiovascular Diseases
;
Case-Control Studies
;
Cerebral Infarction/complications
;
Female
;
Humans
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Risk Factors
;
Stroke/etiology/*prevention & control
;
Warfarin/adverse effects/*therapeutic use
10.Idiopathic Normal-Pressure Hydrocephalus Patient With an Ataxic Gait as the Predominant Presenting Manifestation.
Kyunghun KANG ; Seong Don SEO ; Sung Kyoo HWANG ; Jong Geun SEO ; Jin Sung PARK ; Sung Pa PARK ; Ho Won LEE
Journal of the Korean Neurological Association 2014;32(3):198-201
A 43-year-old man presented with progressive ataxic gait of 5 months duration. His gait speed was almost normal, and he did not exhibit shuffling, freezing, or festination. A formal neuropsychological evaluation revealed a deficit in visuospatial function and memory with mild frontal dysfunctions. Brain MRI revealed communicating hydrocephalus with an Evans' ratio of 0.32. After CSF removal by lumbar puncture the patient showed a marked improvement in gait as well as frontal lobe functions, and was finally diagnosed as having idiopathic normal-pressure hydrocephalus.
Adult
;
Brain
;
Cerebrospinal Fluid
;
Freezing
;
Frontal Lobe
;
Gait*
;
Humans
;
Hydrocephalus*
;
Magnetic Resonance Imaging
;
Memory
;
Spinal Puncture

Result Analysis
Print
Save
E-mail